SCHEMBL8595771

SCHEMBL8595771

COc1ccc(C(=O)Oc2c[nH]c3c(C(N)=O)cccc23)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.52
ESR2 Q92731 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.49
KMT2A Q03164 5/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
TP53 P04637 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
PARP10 Q53GL7 2/20 0.43
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
PARP1 P09874 1/20 0.43
PARP2 Q9UGN5 1/20 0.43
PARP4 Q9UKK3 1/20 0.43
PRSS1 P07477 2/20 0.42
ACR P10323 2/20 0.42
MAPT P10636 4/20 0.42
GAA P10253 1/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28744517 0.81 SMN1; SMN2 (0.46) ESR1ESR2L3MBTL1KMT2ASMN1; SMN2
SCHEMBL5238691 0.76 KDM4E (0.43) ESR1ESR2L3MBTL1KMT2ASMN1; SMN2
SCHEMBL8593494 0.76 PDPK1 (0.42) L3MBTL1KMT2ASMN1; SMN2PARP1MAPT
SCHEMBL8591739 0.75 CLEC4M (0.42) L3MBTL1KMT2ASMN1; SMN2PARP1MAPT
SCHEMBL4590419 0.74 PDPK1 (0.40) L3MBTL1KMT2APARP1GAAKDM4E
SCHEMBL9117853 0.72 ALDH1A1 (0.55) ESR1ESR2L3MBTL1KMT2ASMN1; SMN2
SCHEMBL311792 0.71 KMT2A (0.62) ESR1ESR2L3MBTL1KMT2ACA1
SCHEMBL21159215 0.70 KMT2A (0.67) ESR1ESR2L3MBTL1KMT2ASMN1; SMN2
SCHEMBL8594220 0.70 CLEC4M (0.38) KMT2AGAAKDM4EALDH1A1HPGD
P-Anisic Acid SCHEMBL8595768 0.69 PDPK1 (0.67) KMT2ASMN1; SMN2PARP10CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998055115-A1 CARBOXAMIDES USEFUL AS 5-HT1F AGONISTS ELI LILLY AND COMPANY (US) 1998-12-10 WO disclosed